Part D Specialty Tier Reform May Find Opening In 21st Century Cures Bill
Executive Summary
Stakeholders ask House legislators to revise the Cures proposal to include changes in Part D specialty drug cost sharing, clarify how companies can communicate product economic data, and make allowances for new drug costs in alternative Medicare payment models being developed.